Previous Article | Next Article ![]()
Infect Immun, February 1998, p. 451-461, Vol. 66, No. 2
Department of Bacteriology, University of
Wisconsin, Madison, Wisconsin 53706
Received 4 September 1997/Returned for modification 21 October
1997/Accepted 10 November 1997
This study examines B-cell immunoglobulin (Ig) class-switching
events in the context of parasite antigen-specific Th-cell responses in
experimental African trypanosomiasis. Inbred mice were infected with
Trypanosoma brucei rhodesiense, and the coordinate stimulation of Th-cell cytokine responses and B-cell responses to the
trypanosome variant surface glycoprotein (VSG) was measured. The
cytokines produced by T cells in response to VSG, at both the
transcript and protein levels, were gamma interferon and interleukin-2 (IL-2) but not IL-4 or IL-5. Isotype profiles of antibodies specific for VSG showed that IgG1, IgG2a, and IgG3 switch responses
predominated; no VSG-specific IgE responses were detected. To determine
whether cryptic IL-4 responses played a role in promoting the
unexpected IgG1 switch response, IL-4 knockout mice were infected; the
cytokine responses and Ig isotype profiles of IL-4 knockout mice were
identical to those of the wild-type control mice except for
dramatically reduced IgG1 levels in response to VSG. Thus, these
results revealed an IL-4-dependent component of the VSG-driven B-cell
Cµ-to-C B-cell responses are tightly
regulated by mechanisms that control clonal expansion and cellular
differentiation. Mature T-dependent B-cell responses to complex
antigens normally are controlled by signals derived from antigen
engagement of the B-cell receptor complex, by signals from interactions
between CD40 and CD40 ligand on antigen-specific B and Th cells, and by
cytokines released from antigen-activated Th cells (1, 6, 13, 19,
38, 48, 54, 58, 66, 70). Following B-cell activation, the spectrum of B-cell immunoglobulin (Ig) isotype responses that develop
is regulated primarily by cytokines released by antigen-stimulated Th
cells at the B-cell-T-cell interface. Classical studies of Ig isotype
regulation have determined that specific subsets of cytokines direct
specific Ig CH gene rearrangements that lead to isotype
switching; the result is expression of different Ig isotypes within
antigen-driven B-cell clones (64). Much of our knowledge of
Ig class-switching events has been derived from carefully controlled
and elegant in vitro studies of B cells stimulated with an array of
antigens, mitogens, or other activating agents. Relatively fewer
studies of Ig isotype switching have been performed in
infectious-disease systems in which Th-cell and B-cell responses to
defined microbial antigens have been examined or in which modulations of host immune responses occur as the result of an infection.
In the present study, we examined parasite antigen-specific antibody
(Ab) isotype responses of mice infected with African trypanosomes. The
plasma membrane of trypanosomes is covered by variant surface
glycoprotein (VSG) homodimers that form a dense molecular surface coat
(9, 71). VSG molecules are immunodominant antigens which
serve as potent stimulators of the immune system, and Abs to exposed
VSG determinants destroy parasites expressing a specific VSG phenotype;
however, trypanosomes have the capacity to evade the host immune system
by undergoing extensive antigenic variation in which different VSG
genes are expressed (8, 28, 40). In addition to VSG-specific
B-cell responses, Trypanosoma brucei
rhodesiense-infected mice mount Th1-cell responses to VSG molecules displayed by variant antigenic types (VATs) of the LouTat 1 serodeme (28, 29, 46). These T-cell responses are mediated by This study characterizes for the first time the cytokine basis for Ig
class switching in African trypanosomiasis. The results reveal that
unexpected B-cell Ab isotype switch responses can occur during
infection in the presence of polarized Th-cell responses and suggest
that cryptic cytokine responses and/or alternative Ig class-switching
mechanisms may be activated during African trypanosome infections.
(Portions of this work were completed as part of the requirements for
the Ph.D. degree [L. Schopf] and M.S. degree [X.-J. Bi] of the
University of Wisconsin.)
Animals.
Mice with the B10.BR and C57BL/6 genetic
backgrounds are robust B-cell responders to the VSG molecule and are
relatively resistant when infected with trypanosomes of the LouTat 1 serodeme (11, 14, 26, 27). For this reason, adult male
B10.BR/SgSnJ and C57BL/6J mice as well as athymic nude,
interleukin-4 (IL-4) knockout, and gamma interferon (IFN- Trypanosomes.
Frozen stabilates of T. b.
rhodesiense VATs LouTat 1 and LouTat 1.5 were thawed and used for
infection. To expand trypanosome stabilates for the purposes of
establishing experimental infections, Swiss mice were immunosuppressed
with cyclophosphamide (Cytoxan; 300 mg/kg of body weight [Mead Johnson
and Co., Evansville, Ind.]) before being infected with the desired
VAT. This treatment effectively eliminates B-cell responses to the VSG
molecule and prevents immune selection for any minor VATs present
(53). Trypanosomes subsequently were isolated from the blood
of cyclophosphamide-treated mice by a modified procedure
(25). Briefly, animals were exsanguinated from the
retrobulbar sinus into heparinized tubes. The blood was diluted with
PBSG (phosphate-buffered saline [PBS], 1% glucose [pH 8.0, I = 0.217]) and passed over a DEAE-cellulose column
(Whatman, Clifton, N.J.) equilibrated with PBSG; under these
conditions, cellular blood components adhere to the column matrix
whereas trypanosomes pass through. Trypanosomes isolated in this manner were subsequently washed with PBSG by centrifugation at 1,000 × g for 10 min at 4°C and counted. Confirmation of the VSG
phenotype was made by VSG-specific monoclonal Ab (MAb) typing, as we
have described previously (67). To initiate experimental
infections, mice received an intraperitoneal injection of
105 trypanosomes. All infections were monitored at routine
intervals by examining mouse tail blood for the presence of
trypanosomes.
VSG purification and characterization.
The soluble form of
VSG from LouTat 1 and LouTat 1.5 was purified from viable trypanosomes
by established procedures (43, 46, 67). Briefly, purified
washed trypanosomes in PBSG were concentrated by centrifugation. The
trypanosomes were resuspended to 109 cells/ml in PBSG, and
1-ml aliquots were incubated in siliconized tubes at 4°C overnight.
The trypanosome cell suspensions were subsequently shaken at 200 rpm
for 90 min at 25°C and then centrifuged at 1,000 × g
for 20 min at 4°C. The resultant supernatant fluid was concentrated
and dialyzed against PBS in a Centriprep-30 tube (Amicon Corp.,
Danvers, Mass.) by centrifugation. LouTat 1 VSG concentrates were then
passed over a DEAE-cellulose column to select and purify the VSG.
LouTat 1.5 concentrates were passed over an Affi-Gel (Bio-Rad,
Melville, N.Y.) VSG-specific MAb affinity column equilibrated with PBS
(pH 7.5); LouTat 1.5 VSG molecules were eluted with 5× PBS (pH 7.5),
and the eluate was diluted to 1× PBS (pH 7.5) and concentrated by
centrifugation in a Centriprep-30 tube. All VSG samples were assessed
for purity by electrophoresis in sodium dodecyl sulfate-polyacrylamide
gels run under reducing conditions; a single band was seen which
corresponded to an apparent molecular mass of 62 kDa for the LouTat 1 monomer or 61 kDa for the LouTat 1.5 VSG monomer.
Cell cultures.
Single-cell suspensions were prepared from
the spleen (SPC), peripheral lymph nodes (LNC; mesenteric, inguinal and
brachial), and peritoneum (PEC; nonelicited washout cells) of animals,
at different times of infection, by routine methods and procedures described previously (7, 46, 73). Cell suspensions were made
in ice-cold tissue culture medium (RPMI 1640 containing 10% fetal
bovine serum, 16 mM HEPES buffer, 0.3 mg of L-glutamine per
ml, and 50 µg of gentamicin per ml). Erythrocytes were removed by
hypotonic lysis and passage over glass wool to remove cell debris. Cell
viability, as measured by trypan blue exclusion, was routinely greater
than 95% viable cells. All cell cultures were incubated at 37°C in
an atmosphere of 5% CO2 in air.
Cytokine assays.
SPC, LNC, and PEC from normal and infected
mice were cultured for 12 to 48 h in the presence of medium alone,
concanavalin A (ConA), or VSG; in selected instances, trypanosome
whole-cell extracts (WCE) prepared by sonication of sterile viable
trypanosomes were added to lymphocyte cultures (30).
Cytokines present in the culture supernatant fluids following
stimulation were assessed by enzyme-linked immunosorbent assay (ELISA).
Immulon-4 (Dynatech) ELISA plates were coated with cytokine-specific
capture Ab overnight at 4°C, washed four times with PBS-0.05% Tween
20, and blocked for 30 min with PBS-2% bovine serum albumin at
37°C. After a subsequent washing step, the cytokine standards or
supernatant fluids were added to the wells, which were then incubated
for 2 h at 37°C or overnight at 4°C. The wells were washed
four times and incubated with secondary (IFN- Antibody isotype ELISAs.
Sera from normal and infected mice
were used in Ab isotype-specific ELISAs. Immulon-4 plates were coated
with purified VSG antigen at 4 µg/ml overnight at 4°C. The plates
then were washed, blocked, and washed again as described for the
cytokine ELISAs. A dilution series of individual serum samples from
different time points of infection was added to wells in triplicate,
the wells were incubated for 2 h at 37°C, and the samples were
given another wash. The VSG-specific ELISA plates then were incubated
with horseradish peroxidase (HRP)-conjugated rat anti-mouse IgM, IgG1,
IgG2b, IgG3, or IgA (Zymed), HRP-conjugated sheep anti-mouse IgG2a
(Sigma), or biotinylated rat anti-mouse IgE (provided by Colleen Hayes) for 1 h at 37°C. The plates were washed four times, the
o-phenylenediamine substrate (Sigma Chemical Co.) for the
HRP conjugates was added, and the assay mixture was developed for 10 min at 25°C in the absence of light. The optical density reading at
490 nm for each well was determined with an automated plate reader.
QC-PCR.
Total RNA was purified from freshly isolated and 12- to 48-h-cultured SPC, LNC, and PEC (with or without VSG or ConA) from uninfected and infected mice by using a protocol optimized for Ultraspec RNA (Biotecx Laboratories, Inc., Houston, Tex.).
Single-stranded cDNA was generated from RNA by using oligo(dT) priming
and avian myeloblastosis virus reverse transcriptase (Promega, Corp.,
Madison, Wis.) by a standard protocol. The resulting single-stranded
cDNA provided a template for gene-specific quantitative competitive PCR
(QC-PCR) amplification (41, 42, 51, 52) with commercial 5'
and 3' oligonucleotide primers obtained from Clontech (Palo Alto,
Calif.) or synthesized by the University of Wisconsin Biotechnology Center. The primers used were G3PDH (upper) (5' TGA AGG TCG GTG TGA ACG
GAT TTG GC 3'), G3PDH (lower) (5' CAT GTA GGC CAT GAG GTC CAC CAC 3'),
IFN- Th1-cell cytokine responses to VSG.
Recent studies in our
laboratory showed for the first time that VSG-specific T-cell responses
occur during trypanosome infections (29, 46, 47). The
present study extends this work to the B-cell compartment by examining
T-dependent B-cell responses to VSG in the context of VSG-specific
Th-cell responses. As shown in Fig. 1, a
prominent VSG-induced IFN-
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Interleukin-4-Dependent Immunoglobulin G1 Isotype Switch in the
Presence of a Polarized Antigen-Specific Th1-Cell Response to the
Trypanosome Variant Surface Glycoprotein

![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
1 switch. We speculate that an IL-4 response is mediated
primarily by cells other than T lymphocytes since IL-4-secreting but
parasite antigen-unresponsive, "background" cells were detected in
all infected mice and since infected nude mice also
displayed a detectable IgG1 switch response. Overall, our results
suggest that B-cell clonal stimulation, maturation, and Ig class
switching in African trypanosomiasis may be partially regulated by
unusual mechanisms that do not include antigen-specific Th1 or Th2
cells.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

TCR+ CD4+ cells that recognize VSG
peptides in an antigen-presenting cell-dependent and major
histocompatibility complex class II-dependent manner (46).
Since infected mice make prominent T-cell-dependent B-cell responses to
VSG (11, 14, 26, 27, 45), the relationship between parasite
antigen-driven Th-cell cytokine responses and Ab class-switching
responses could be evaluated.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
) knockout
mice with the C57BL/6 genetic background were used for experimental
infections in this investigation; all the animals were obtained from
The Jackson Laboratory (Bar Harbor, Maine). Outbred Swiss mice obtained
from Harlan Sprague-Dawley (Madison, Wis.) were used for expanding
trypanosome stabilates in vivo. All animals were housed in
University-approved facilities and were handled strictly according to
National Institutes of Health and University of Wisconsin Research
Animal Resource Center guidelines.
ELISA) or detector Ab
(IL-2, IL-4, and IL-5 ELISAs). IFN-
plates were washed again and
incubated with detector Ab. All the ELISA plates were developed, after
a final wash step, with the Vectastain ABC-AP kit (Vector Laboratories,
Burlingame, Calif.) as specified by the manufacturer, and the optical
density reading for each well was determined with an automated plate
reader at 405 nm. Reagents for the IFN-
ELISA were R46A2 ascites
(capture Ab) and polyclonal rabbit anti-IFN-
(secondary Ab; kindly
provided by Colleen Hayes, University of Wisconsin). These reagents
were used at optimal dilutions of 1:3,000 and 1:1,000, respectively. The detector Ab used was biotinylated goat anti-rabbit Ig at a 1:20,000
dilution (Sigma Chemical Co., St. Louis, Mo.). The reagents for the
IL-2 and IL-4 ELISAs were obtained from Pharmingen (San Diego, Calif.);
both the capture and detector Abs for each cytokine were used at 0.5 µg/ml. Additionally, the biological activity of IL-2 and IL-4 was
monitored by the CTLL-2 cell stimulation assay in the presence or
absence of inhibitory concentrations of MAb to IL-2 or IL-4 (S4B6 and
11B11, respectively) (7). A commercially available ELISA kit
from Genzyme (Cambridge, Mass.) was used, as specified by the
manufacturer, for the detection of IL-5 in culture supernatant fluids.
Enzyme-linked immunospot (ELISPOT) assays were performed by standard
methods (7). Different concentrations of cells from 12-h
cultures in tissue culture medium, medium plus VSG, or rat anti-CD3
(Pharmingen) as described previously (47) were plated into
the wells of 96-well microtiter plates containing a nitrocellulose base
(Millititer, HA, Millipore Corp.); these wells were pretreated with the
relevant capture Abs used above for the cytokine ELISAs. After a 20-h
incubation period at 37°C under 5% CO2 in air, the cells
were removed, the wells were washed, and relevant detector Abs and
reagents were added as above. The cytokine spots were counted under a
dissecting microscope.
(upper) (5' CAT CTT GGC TTT GCA GCT CTT CCT CAT GGC 3'),
IFN-
(lower) (5' TGG ACC TGT GGG TTG TTG ACC TCA AAC TTG GC 3'),
IL-2 (upper) (5' ATG TAC AGC ATG CAG CTC GCA TC 3'), IL-2 (lower) (5'
GGC TTG TTG AGA TGA TGC TTT GAC A 3'), IL-4 (upper) (5' GAG ATC ATC GGC
ATT TTG AAC 3'), and IL-4 (lower) (5' GCT CTT TAG GCT TTC CAG GAA GTC
3'). To competitively quantitate the mRNA levels, a dilution series of
PCR MIMICS (Clontech) was added to the PCR amplification mixtures
containing the experimental cDNA samples. The PCR MIMICS used were
nonhomologous, GC-neutral DNA molecules containing relevant cytokine
primer sites at each end; because the molar quantity of the competitive
MIMICS at the start of the PCR reaction was known, the actual number of
target DNA molecules in the cDNA preparations could be determined. To control for experimental variability, each calculation was normalized to levels of a housekeeping gene, glyceraldehyde-3-phosphate
dehydrogenase (G3PDH), in each mRNA sample. Briefly, cDNA samples,
MIMICS, reaction buffer, and PCR primers were mixed and heated at
94°C for 3 min and cooled to 40°C, AmpliTaq DNA
polymerase (Perkin-Elmer, Branchburg, N.J.) was added, and the products
were amplified under the following conditions: initial denaturation at
94°C for 1 min followed by 25 to 35 cycles of denaturation (94°C
for 1 min), annealing (60°C for 2 min [55°C for 2 min for IL-4]),
and extension (72°C for 3 min), with a final extension at 72°C for
7 min. The reaction products were evaluated by agarose gel
electrophoresis (1.2% agarose) and ethidium bromide staining.
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
response was made during infection of
mice with T. b. rhodesiense LouTat 1.5. This cytokine response was seen as early as day 4 of infection, primarily in the SPC
population. As the time of infection progressed, the IFN-
response
declined in the SPC cultures but increased within the PEC and LNC
compartments. VSG-induced IFN-
responses peaked between days 7 and
14 of infection (Fig. 1A), at time points after the infecting VAT
expressing the relevant VSG had been cleared, but gradually diminished
thereafter to undetectable levels. Therefore, infection induced a
VSG-specific T-cell response that was characterized in part by IFN-
production; these responses, as well as the IL-2 responses (see below),
were mediated by CD4+ T cells (46). At some time
points of infection, significant levels of IFN-
were spontaneously
released by cells cultured in medium alone (Fig. 1A) and significant
amounts of IFN-
were detectable in the sera of infected mice
(12, 46); these observations may be explained by
the ongoing stimulation of Th cells by VSG as well as other
trypanosome antigens. Furthermore, trypanosome-derived T-lymphocyte
triggering factor (TLTF) may cause CD8+ T cells to secrete
IFN-
in an antigen-nonspecific manner during infection (3, 36,
37).

View larger version (30K):
[in a new window]

View larger version (53K):
[in a new window]
FIG. 1.
Th1-cell pattern of cytokines detectable after VSG
stimulation of lymphocytes from T. b. rhodesiense LouTat
1.5-infected B10.BR mice. (A) ELISA and bioassay for cytokines secreted
by SPC, LNC, and PEC harvested from control (N) and 2-week-infected (I)
mice; the cells were stimulated with LouTat 1.5 VSG (10 µg/ml), and
the culture supernatant fluids were harvested at 24 hr. (B) QC-PCR
analysis of cytokine transcripts expressed in PEC of normal (N) or
2-week-infected (Inf) mice, either before culture (freshly isolated
[FI]) or after 24-h culture stimulation with medium, LouTat 1.5 VSG
(10 µg/ml), or ConA (0.5 µg/ml). The MIMICS amplification product
is the upper ethidium bromide-stained band in the IFN-
and IL-4
samples and the lower band in the IL-2 samples; the numbers represent
the numbers of cytokine transcripts detectable per 1,000 G3PDH
transcripts. Stimulation of cells with heterologous VSG or other
unrelated antigens gave no detectable response in either the
serological tests or the transcript assays. The results shown are from
a single representative experiment of more than 10 separate experiments
performed over a 4-year period.
, IL-2 synthesis was compartmentalized largely to the peritoneal
T-cell population, as we have described previously (46).
Figure 1A shows IL-2 levels detectable in cultures derived from normal
and LouTat 1.5-infected mice on day 14 postinfection. Only T cells from
the infected-mouse peritoneal compartment produced IL-2 in response to
VSG stimulation; the highest level of IL-2 was detected on day 14, as
shown. The inclusion of blocking Ab to the IL-2 receptor (IL-2R) in
culture medium did not reveal any differences in the observed
compartmentalization; therefore, IL-2 utilization by activated cells
was not a factor (data not shown). We have previously reported that the
appearance of systemically emerging VATs later in infection also
triggers compartmentalized IL-2 responses to VSG (46); in
all results obtained to date, neither the cytokine patterns nor the Ig
isotype patterns observed (below) were dependent upon the route of
infection or infection with any particular VAT of the LouTat 1 serodeme.
Absence of Th2-cell cytokine responses to VSG during
infection.
Lymphocyte supernatant fluids from cultures of normal
and infected mice were evaluated by ELISA for Th2-cell-associated
cytokines. In contrast to IFN-
and IL-2 production, no significant
IL-4 production in response to VSG stimulation was detected in SPC, LNC, or PEC populations at any time during infection; all values were
below the accurate detection limits of 25 pg/ml in the ELISA (Fig. 1A).
The addition of blocking Ab to the IL-4R during lymphocyte culture
stimulation with VSG failed to reveal the presence in supernatant
fluids of any IL-4 that may have otherwise been consumed by cells in
culture (data not shown). The testing of supernatant fluids for
biologically active IL-2 and IL-4 was also done in CTLL-2 bioassays; as
with results from ELISAs, there was evidence for IL-2- but not
IL-4-mediated stimulation of cells (Fig. 1A). These results were also
confirmed by ELISPOT assays (below).
activation of macrophages (data not shown). To determine if
IL-4 or IL-5 responses to trypanosome antigens other than VSG were
being made, lymphocytes from infected animals were cultured with WCE of
heterologous VATs in which the antigenic makeup differed only in terms
of the VSG. In no cultures were IL-4 or IL-5 responses to WCE
detectable; however, similar to the response to purified VSG (Fig. 1A),
IFN-
and IL-2 were secreted in response to WCE.
ELISPOT assay results (Fig. 2) largely
paralleled the cytokine secretory responses noted above, with one
exception: infection-induced "background" IL-4 cytokine spots were
detected in all medium control cell cultures within a few days of
infection. These IL-4 responses were not further upregulated following
stimulation with VSG (Fig. 2) or with WCE. Therefore, while an increase
in the background numbers of IL-4-secreting cells was detectable during
trypanosome infection, these cells did not respond to parasite antigens
and appear to be distinct from T cells responding to VSG.
|
Determination of cytokine mRNA levels by QC-PCR.
Cytokine
transcript levels during infection were evaluated by a sensitive method
(Fig. 1B). Total RNA was extracted from freshly isolated SPC and PEC
populations after they were harvested from normal and infected mice, as
well as from cells that had been stimulated for a further 24 h
with medium, ConA, or VSG. QC-PCR analyses of cytokine transcripts were
subsequently performed. Freshly isolated SPC and PEC populations from
infected mice exhibited detectable levels of IFN-
, IL-2, and IL-4
transcripts compared to the same cells from normal mice (Fig. 1B);
however, these basal cytokine transcript levels disappeared during a
24-h culture period in the presence of medium. In contrast, cells from
infected PEC populations revealed a marked increase in the levels of
both IFN-
and IL-2 transcripts when stimulated with ConA or VSG
(Fig. 1B), while SPC revealed a VSG-specific upregulation in IFN-
transcript levels only. An examination of IL-4 transcript levels in VSG
or WCE-stimulated cells during infection revealed that there was no
detectable antigen-induced upregulation of transcript in any of the
cell populations (Fig. 1B).
VSG-specific Ab isotype responses.
Having demonstrated that
Th-cell stimulation by the VSG molecule during infection produced a
predominant Th1-cell cytokine response, we examined the emerging Ab
response to VSG in the context of helper-cell cytokine responses. Ab to
VSG appeared rapidly following infection with trypanosomes of the
T. b. rhodesiense LouTat 1 serodeme, as we have previously
described (14, 27, 28, 44, 45, 68); as in earlier studies,
the peak VSG-specific Ab responses occurred by days 7 to 14 and then
the responses gradually declined (Fig.
3). When we determined the isotypes of
VSG-specific Ab, we found that the predominant VSG-specific Ab isotypes
made during infection were IgM, IgG1, IgG2a, and IgG3; no IgE was
detectable (<10 ng/ml) and only minimal amounts of IgG2b and IgA were
detectable. The switch to IgG1 was unexpected because high levels of
IFN-
are present in infected mice and this cytokine is known to
inhibit a switch to IgG1 and IgE, in addition to inducing a switch to IgG2a (1, 19, 21, 23, 38, 48, 58, 66). Furthermore, IL-4 is
known to be involved in blocking IgG2a production (23); however, no detectable IL-4 or other Th2 cytokines were secreted during
infection in response to VSG stimulation.
|
Ig isotype responses and T-cell cytokine profiles of athymic mice
and IL-4 and IFN-
knockout mice.
To determine the extent of
T-cell involvement in the IgG1 switch, C57BL/6 athymic nude
mice were infected and examined for their B-cell responses. All
nude mice made prominent IgM and IgG3 but not IgG2a Ab
responses to VSG (Fig. 4). These results
show that the IgM and IgG3 responses are relatively T independent but that the IgG2a response is strictly T dependent. The nude
mice also made a detectable IgG1 response, although the magnitude was lower than that of the thymus-intact mice (Fig. 4). This result shows
that the IgG1 response is relatively T-cell independent, in contrast to
the IgG2a response, and suggests that the IgG1 switch factors(s) is
produced in animals lacking significant numbers of peripheral Th cells.
Although we could not detect VSG-inducible IFN-
, IL-2, or IL-4
responses in infected nude mice, the observation of a
T-independent IgG1 switch is tempered by the fact that small numbers of
peripherally maturing T cells present in nude mice may
influence B-cell maturation (49).
|
and IL-2 responses to VSG like the wild-type
control mice (Fig. 2); however, the Ab isotype profile differed from
that of wild-type mice in that there was a loss of the IgG1 switch response to VSG (Fig. 5). This result
clearly demonstrates the IL-4-dependent nature of the IgG1 switch
responses of trypanosome-infected mice to VSG. In a related experiment,
the immune responses of IFN-
knockout mice were also examined; these
animals made IL-2 but not IFN-
or IL-4 responses to VSG (Fig. 2);
the Ig isotype pattern revealed loss of the IgG2a response to VSG but
no major modulations in any of the other isotypes (Fig.
6). This result clearly shows the
dependence of the IgG2a switch response on IFN-
.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The mechanisms that regulate B-cell responses during African trypanosomiasis have not been previously elucidated. In other model systems, Th-cell responses are known to play a central role in the regulation of B-cell growth and differentiation by providing both membrane-activating signals and cytokines that regulate the Ig class switch responses of antigen-activated B cells (1, 6, 13, 19, 38, 50, 54, 70). However, until recently, Th-cell responses during African trypanosomiasis were thought to be completely suppressed (10, 28, 39, 65, 72, 73). Therefore, we had examined other immune mechanisms that might regulate B-cell responses to parasite antigens, including studies showing that the downregulation of VSG-specific B-cell responses was associated with anti-idiotypic responses (67, 68). There was no substantive evidence, however, for an idiotypic network operating during upregulation of VSG-specific B-cell responses in infection.
Subsequent studies in our laboratory revealed qualitative and quantitative differences in the VSG-specific Ab responses of infected athymic and thymus-intact mice (29, 45), suggesting that stimulation of the VSG-specific B-cell response involved both T-independent and T-dependent mechanisms, despite the apparent evidence for the suppression of T-cell responses to parasite antigens (39). Another clue that Th-cell responses occurred during trypanosome infections came from VSG sequence analysis (4, 43). The tertiary and secondary structures of VSG molecules have been shown by X-ray crystallography studies to be highly conserved (4). However, this conservation is not reflected at the primary structural level, since VSG molecules, including LouTat 1 serodeme VSGs, exhibit extensive amino acid sequence variation throughout the molecule (4, 43). Sequence analysis also revealed that "hypervariable" regions were dispersed throughout LouTat 1 and other VSG molecules and included those regions predicted not to be exposed to VSG-specific Abs (43); it was proposed that such variable regions in non-Ab-accessible sites may have been selected for by hypothetical Th-cell responses to processed VSG determinants (4, 29). However, these types of analyses provided only indirect evidence for Th-cell responses to the VSG molecule during infection. A major advance in terms of understanding T-dependent mechanisms of immune system stimulation in trypanosomiasis came from recent work in which it was demonstrated that, despite active suppression of T-cell proliferative responses by products of activated macrophages (10, 47, 65), cytokines were produced in response to VSG stimulation (46). These results provided the first direct evidence for VSG-specific Th-cell responses during infection. We hypothesized, therefore, that Th-cell cytokines may play a crucial role in the upregulation of T-dependent B-cell responses to the VSG molecule (29).
In the present study, we examined host B-cell responses to VSG by
using a mouse model system and VATs of the T. b.
rhodesiense LouTat 1 serodeme. The B10.BR/SgSnJ and
C57BL/6J mouse strains make a strong VSG-specific Ab response to
VSG molecules displayed by the infecting trypanosome VAT; this
response, coupled with subsequent B-cell responses to VSG molecules
displayed by emerging VATs, permits infected mice to control
parasitemias (28). The work presented here provides a
further characterization of Th-cell responses to the VSG molecule by
defining the VSG-specific B-cell responses of trypanosome-infected mice
at the isotype level in the context of defined Th-cell cytokine
responses. Taken together, the data provide compelling evidence for a
predominant VSG-specific Th1-cell cytokine response and the apparent
absence of a Th2-cell response to VSG during trypanosome infections.
The differentiation of Th0 cells to the Th1 phenotype is not due to any
intrinsic characteristics of the VSG molecule itself, since some T-cell lines derived from animals immunized with VSG in the absence of infection produced both Th1- and Th2-cell-associated cytokines (46); rather, the polarization appears to be dependent upon a strong and early IFN-
-independent stimulation of macrophage IL-12
production, coupled with an inhibitory effect directly on Th2-cell
outgrowth, within the first few days of infection (30a).
One unusual feature of the work presented here is the unexpected Ab
isotype profile generated in response to the VSG molecule. Much of the
current information regarding Ig class-switching mechanisms has been
derived from in vitro studies with lipopolysaccharide-activated or
Ab-stimulated B cells in the presence of defined cytokines. Specific
cytokines appear to activate Ig gene site-specific recombinases that
splice out intervening CH gene sequences, producing
rearrangements giving new VH-CH combinations
(64). Citing classical examples (5, 6, 15, 16, 20, 55,
59, 60, 64), it is well known that IL-4 promotes Cµ-to-C
1
and -C
switching events within Ig CH genes of activated
B-cell clones while IFN-
, in contrast, promotes Cµ-to-C
2a and
-C
3 switching events; furthermore, IL-4 inhibits C
2a isotype
switching while IFN-
inhibits C
1 and C
switching events. Thus,
the cytokine products of antigen-stimulated Th1 and Th2 cells have been
shown to exert distinct regulatory and counterregulatory effects on the
target B cells with which they react. While this work has provided an
excellent foundation for our understanding of the molecular mechanisms
of class switching, results presented here and elsewhere in the context
of infectious-disease model systems (17, 31, 32, 35, 56-58,
61) have modified earlier hypotheses based on classical
approaches. Considering the complexities of antigens presented by
pathogens and the intricate immunoregulatory events triggered by
certain infections, it is not surprising that observations concerning
Ig class switching are different from those derived from earlier,
better-defined in vitro systems. The data presented here, in which we
see a polarized antigen-specific Th1-cell response and antigen-specific
B-cell IgG1, IgG2a, and IgG3 switch responses, provide an interesting comparison to some of the current models of Ig class-switching events.
First, it was apparent that the trypanosome VSG surface coat, coupled
with other factors, provides T-independent signals to B cells, as we
have described previously (29, 45); these signals were
sufficient to drive not only an IgM response but also part of the IgG1
switch response (see the discussion on IL-4, below), as well as the
IgG3 response (Fig. 4). It has long been established by in vitro and in
vivo studies that IFN-
is responsible for the IgG2a switch response.
In trypanosome infections, high levels of IFN-
were secreted in
response to the VSG molecule and other parasite antigens (Fig. 1 and 2)
(46) and very high levels of IFN-
are detectable in the
sera of infected mice (12); as expected, high levels of
IFN-
-dependent and VSG-specific IgG2a were detectable (Fig. 3, 4,
and 6). Studies suggesting that IFN-
is also responsible for IgG3
switching events (6) are not directly supported by our
results, since both nude and IFN-
knockout mice exhibited
strong IgG3 responses to VSG (Fig. 4 and 6). IL-4 has been shown to
promote a switch to IgG1 and IgE as well as to suppress IgG2a
production; although no IL-4 secreted in response to trypanosome antigens was detected in our system, there clearly was an
IL-4-dependent, but partially T-independent, component to the
VSG-specific IgG1 switch, as shown by the IL-4 knockout and
nude mouse studies (Fig. 4 and 5). Of interest is that even
though the IgG1 response was IL-4 dependent, no detectable IgE was
produced; furthermore, the levels of IFN-
present during infection
appeared to exhibit no apparent downregulatory influence on the IgG1
switch response (Fig. 3 and 6). This is surprising since the inhibitory
effect of IFN-
is believed to predominate even in the presence of
Th2 cytokines (22). In a similar vein, the low levels of
cryptic IL-4 produced were insufficient to downregulate the IgG2a
responses of infected mice (Fig. 3 and 5).
The cellular source of IL-4 that drives the IgG1 switch in
trypanosome-infected mice is not clear. We could not detect an increase
in the level of IL-4 transcripts, serologically detectable IL-4
protein, or biologically active IL-4 after stimulation with VSG or
other trypanosome antigens (Fig. 1 and 2). However, IL-4 transcripts
were detectable in freshly isolated, but not culture-stimulated, cells from infected mice (Fig. 1B), and IL-4-secreting
"background" cells were detectable by the ELISPOT assay,
in which the numbers of such cells did not increase following antigenic
stimulation (Fig. 2), suggesting either that the cells did not express
receptors for trypanosome antigens or that the cells were unable to
undergo clonal expansion when stimulated. Thus, VSG-nonresponsive cells appear to be the source of low levels of IL-4 that are sufficient to
drive the C
1 switch in VSG-specific B cells. In all likelihood, this
cellular source may be non-Th2 cells such as 
T cells or mast
cells, basophils, or NK cells (24, 49, 62, 63, 74). Although
we cannot formally rule out a failure to detect very small numbers of
VSG- or other parasite antigen-reactive Th2 cells as the source of
IL-4, further support for a role of non-T cells is based on the
detection of IL-4 transcripts in trypanosome-infected scid
and RAG-2 knockout mice (30a). Another contributing source of IL-4 may be CD8+ T cells stimulated by TLTF (3, 36,
37). A paper that appeared while this study was in progress
showed that IL-4- and IFN-
-secreting cells appear after the
stimulation of nonimmune cells with TLTF, which binds to the CD8
molecule and triggers cytokine synthesis (2). Thus, there
may be a CD8+ T-cell component that nonspecifically
releases IL-4 after exposure by infection to TLTF and contributes to
the IL-4-driven IgG1 switch; this supposition is supported by the
nude mouse data in the present study, in which there is an
identifiable T-dependent as well as a T-independent component to the
switch (Fig. 4). That we found no perturbation in IL-4-secreting
VSG-nonresponsive cells in IFN-
knockout mice (Fig. 2) suggests
that, if TLTF is involved, the ability to induce IL-4 production is
neither linked to the production of IFN-
nor negatively regulated by
it.
Another hypothesis to explain the IgG1 switch response to VSG is that
precommitted VSG-specific memory Th2 cells exist in uninfected mice and
that these cells may, upon VSG exposure during an infection, interact
with VSG-specific B cells and secrete IL-4 to cause the switch in the
absence of further significant clonal expansion. There are data from
other model systems that support this contention (69), and
the early appearance of parasite-specific IgG responses relative to the
appearance of IgM in experimental trypanosomiasis has been described
previously (18). Furthermore, we have recently demonstrated
the presence of VSG-cross-reactive natural autoantibodies in the sera
of uninfected animals, including germ-free mice, suggesting that there
may be VSG-primed Th and B cells in normal mice (33, 34). We
have demonstrated that VSG-stimulated T cells undergo limited clonal
proliferation during infection due to inhibitory effects of nitric
oxide and prostaglandins (47) and that high levels of IL-12
and IFN-
are released early in infection and can inhibit the
outgrowth of Th2 cells (30a); it is conceivable, therefore,
that if precommitted Th cell populations exist and if they express the
Th2 cytokine phenotype and recognize epitopes shared by host
cytoskeletal antigens and VSG (33, 34), they may be able to
provide limited IL-4-mediated signals to VSG-specific B cells but be
unable to proliferate to the point of being detectable in culture.
However, more recent data from our laboratory showed that mature Ig
transcripts containing VSG-specific VH plus C
1 or C
2a
sequences were detectable only after 1 week of infection; these
transcripts represented dominant Ig VH family responses to
VSG determinants in infected animals, and there was no difference in
the time of appearance of antigen-specific C
1 transcripts compared
to C
2a transcripts (3a). Thus, the potential presence of
an early (or precommitted) Th2- or B-cell response does not seem to
skew the timing of appearance of the C
1 switch response relative to
other more predictable switching events.
In summary, this paper provides important new insights into the
regulation of VSG-specific B-cell responses in African trypanosomiasis and extends our previous work on VSG-specific Th1 cell stimulation during infection (29, 46). The most surprising observation was the production of VSG-specific IgG1 in an IL-4-dependent manner, in
the absence of demonstrable antigen-specific Th2-cell responses. Based
on the aggregate evidence presented here, it is probable that
non-
/
TCR+ T cells are the source of IL-4 in
trypanosome-infected nimals and that these cells are stimulated
to produce IL-4 in a manner that is antigen independent and
insensitive to negative regulation by IFN-
. Overall, our results
provide a foundation for studying the alternative regulation of Ig
class-switching mechanisms in African trypanosomiasis by
non-antigen-specific cells that may be part of the innate immune
system.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by funds from the National Institutes of Health (AI-22441).
We thank Jim Schrader and John Barkei for their excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Bacteriology, University of Wisconsin, AHBS Building, 1655 Linden Dr., Madison, WI 53706. Phone: (608) 262-2596. Fax: (608) 265-4899. E-mail: jmm{at}ahabs.wisc.edu.
Present address: Genetics Institute, Andover, MA 01810.
Editor: V. A. Fischetti
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abbas, A. K., H. J. Burstein, and S. A. Bogen. 1993. Determinants of helper T cell-dependent antibody production. Semin Immunol. 5:441-447[Medline]. |
| 2. | Bakhiet, M., L. Jansson, P. Buscher, R. Holmdahl, K. Kristensson, and T. Olsson. 1996. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4. J. Immunol. 157:3518-3526[Abstract]. |
| 3. | Bakhiet, M., T. Olsson, C. Edlund, B. Hojeberg, K. Holmberg, J. Lorentzen, and K. Kristensson. 1993. A Trypanosoma brucei brucei-derived factor that triggers CD8+ lymphocytes to interferon-gamma secretion: purification, characterization and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand. J. Immunol. 37:165-178[Medline]. |
| 3a. | Bi, X.-J., and J. M. Mansfield. Unpublished data. |
| 4. | Blum, J. L., J. A. Down, A. M. Gurnett, M. Carrington, M. J. Turner, and D. C. Wiley. 1993. A structural motif in the variant surface glycoproteins of Trypanosoma brucei. Nature 362:603-609[Medline]. |
| 5. |
Coffman, R. L., and J. Carty.
1986.
A T cell activity that enhances polyclonal IgE production and its inhibition by interferon- .
J Immunol.
136:949[Abstract].
|
| 6. | Coffman, R. L., D. A. Lebman, and P. Rothman. 1993. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol. 54:229-270[Medline]. |
| 7. | Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1991. . Current protocols in immunology. Greene Publishing Associates and Wiley Interscience, New York, N.Y. |
| 8. | Cross, G. A. 1990. Cellular and genetic aspects of antigenic variation in trypanosomes. Annu. Rev. Immunol. 8:83-110[Medline]. |
| 9. | Cross, G. A. 1975. Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei. Parasitology. 71:393-417[Medline]. |
| 10. | Darji, A., A. Beschin, M. Sileghem, H. Heremans, L. Brys, and P. Debaetselier. 1996. In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression. Infect. Immun. 64:1937-1943[Abstract]. |
| 11. | De Gee, A. L., R. F. Levine, and J. M. Mansfield. 1988. Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses. J. Immunol. 140:283-288[Abstract]. |
| 12. | De Gee, A. L., G. Sonnenfeld, and J. M. Mansfield. 1985. Genetics of resistance to the African trypanosomes. V. Qualitative and quantitative differences in interferon production among susceptible and resistant mouse strains. J. Immunol. 134:2723-2726[Abstract]. |
| 13. | DeKruyff, R. H., L. V. Rizzo, and D. T. Umetsu. 1993. Induction of immunoglobulin synthesis by CD4+ T cell clones. Semin. Immunol. 5:421-430[Medline]. |
| 14. | Dempsey, W. L., and J. M. Mansfield. 1983. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J. Immunol. 130:405-411[Abstract]. |
| 15. | Dunnick, W., L. Elenich, J. Berry, D. Albrecht, J. Stavnezer, and J. L. Claflin. 1992. Regulation of switch recombination to the murine gamma 1 gene. Curr. Top. Microbiol. Immunol. 182:143-147[Medline]. |
| 16. |
Elenich, L. A.,
C. S. Ford,
J. T. Collins, and W. A. Dunnick.
1997.
1 heavy chain transgenes are responsive to IFN- repression and CD40 ligation.
J. Immunol.
158:4564-4573[Abstract].
|
| 17. |
Fernandez-Lago, L.,
F. J. Santoyo,
N. Vizcaino, and A. Chordi.
1991.
Class-specific immune response to Yersinia enterocolitica serotype O9 antigens as determined by enzyme-linked immunosorbent assay.
J. Clin. Microbiol.
29:1243-1248 |
| 18. | Finerty, J. F., L. Gasbarre, and L. P. Kendrick. 1984. Kinetics of immunoglobulin and specific antibody responses of CBA mice infected with Trypanosoma rhodesiense. Parasite Immunol. 6:13-22[Medline]. |
| 19. | Finkelman, F. D., J. Holmes, I. M. Katona, J. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333[Medline]. |
| 20. | Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333. |
| 21. | Finkelman, F. D., I. M. Katona, T. R. Mosmann, and R. L. Coffman. 1988. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1022-1027[Abstract]. |
| 22. | Finkelman, F. D., and J. Urban, Jr. 1992. Cytokines: making the right choice. Parasitol. Today 8:311-314. |
| 23. |
Finkelman, F. D.,
J. F. Urban, Jr.,
M. P. Beckmann,
K. A. Schooley,
J. M. Holmes, and I. M. Katona.
1991.
Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody.
Int. Immunol.
3:599-607 |
| 24. | Gauchat, J. F., S. Henchoz, G. Mazzei, J. P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores-Romo, J. Thompson, et al. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340-343[Medline]. |
| 25. | Lanham, S. M., and D. G. Godfrey. 1970. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp. Parasitol. 28:521-534[Medline]. |
| 26. |
Levine, R. F., and J. M. Mansfield.
1981.
Genetics of resistance to African trypanosomes: role of the H-2 locus in determining resistance to infection with Trypanosoma rhodesiense.
Infect. Immun.
34:513-518 |
| 27. | Levine, R. F., and J. M. Mansfield. 1984. Genetics of resistance to the African trypanosomes. III. Variant-specific antibody responses of H-2-compatible resistant and susceptible mice. J. Immunol. 133:1564-1569[Abstract]. |
| 28. | Mansfield, J. M. 1995. Immunobiology of African trypanosomiasis: a revisionist view, p. 477-496. In J. C. Boothroyd, and R. Komuniecki (ed.), Molecular approaches to parasitology. Wiley-Liss, New York, N.Y. |
| 29. | Mansfield, J. M. 1994. T-cell responses to the trypanosome variant surface glycoprotein: a new paradigm? Parasitol. Today 10:267-270. [Medline] |
| 30. |
Mansfield, J. M.,
S. A. Craig, and G. T. Stelzer.
1976.
Lymphocyte function in experimental African trypanosomiasis: mitogenic effects of trypanosome extracts in vitro.
Infect. Immun.
14:976-981 |
| 30a. | Mansfield, J. M., et al. Unpublished data. |
| 31. | Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692[Medline]. |
| 32. | Mond, J. J., Q. Vos, A. Lees, and C. M. Snapper. 1995. T cell independent antigens. Curr. Opin. Immunol. 7:349-354[Medline]. |
| 33. | Muller, N., M. Imboden, E. Detmer, J. M. Mansfield, and T. Seebeck. 1993. Cytoskeleton-associated antigens from African trypanosomes are recognized by self-reactive antibodies of uninfected mice. Parasitology 107:411-417. |
| 34. | Muller, N., J. M. Mansfield, and T. Seebeck. 1996. Trypanosome variant surface glycoproteins are recognized by self-reactive antibodies in uninfected hosts. Infect. Immun. 64:4593-4597[Abstract]. |
| 35. | Nguyen, L., D. M. Knipe, and R. W. Finberg. 1994. Mechanism of virus-induced Ig subclass shifts. J. Immunol. 152:478-484[Abstract]. |
| 36. | Olsson, T., M. Bakhiet, B. Hojeberg, A. Ljungdahl, C. Edlund, G. Andersson, H. P. Ekre, W. P. Fung-Leung, T. Mak, H. Wigzell, U. Fiszer, and K. Kristensson. 1993. CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 72:715-727[Medline]. |
| 37. | Olsson, T., M. Bakhiet, and K. Kristensson. 1992. Interactions between Trypanosoma brucei and CD8+ T cells. Parasitol. Today 8:237-239. [Medline] |
| 38. | Parker, D. 1993. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:331[Medline]. |
| 39. | Paulnock, D. M., C. Smith, and J. M. Mansfield. 1989. , p. 135-144. Antigen presenting cell function in African trypanosomiasis Alan R. Liss, Inc., New York, N.Y. |
| 40. | Pays, E. 1991. Genetics of antigenic variation in African trypanosomes. Res. Microbiol. 142:731-735[Medline]. |
| 41. | Piatak, M., Jr., K. C. Luk, B. Williams, and J. D. Lifson. 1993. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. BioTechniques 14:70-81. [Medline] |
| 42. | Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754. |
| 43. | Reinitz, D. M., B. D. Aizenstein, and J. M. Mansfield. 1992. Variable and conserved structural elements of trypanosome variant surface glycoproteins. Mol. Biochem. Parasitol. 51:119-132[Medline]. |
| 44. | Reinitz, D. M., and J. M. Mansfield. 1988. Independent regulation of B cell responses to surface and subsurface epitopes of African trypanosome variable surface glycoproteins. J. Immunol. 141:620-626[Abstract]. |
| 45. |
Reinitz, D. M., and J. M. Mansfield.
1990.
T-cell-independent and T-cell-dependent B-cell responses to exposed variant surface glycoprotein epitopes in trypanosome-infected mice.
Infect. Immun.
58:2337-2342 |
| 46. | Schleifer, K. W., H. Filutowicz, L. R. Schopf, and J. M. Mansfield. 1993. Characterization of T helper cell responses to the trypanosome variant surface glycoprotein. J. Immunol. 150:2910-2919[Abstract]. |
| 47. | Schleifer, K. W., and J. M. Mansfield. 1993. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:5492-5503[Abstract]. |
| 48. | Schultz, C. L., and R. L. Coffman. 1991. Control of isotype switching by T cells and cytokines. Curr Opin Immunol. 3:350-354[Medline]. |
| 49. | Seder, R. A., W. E. Paul, S. Z. Ben-Sasson, G. S. LeGros, A. Kagey-Sobotka, F. D. Finkelman, J. H. Pierce, and M. Plaut. 1991. Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils. Int. Arch. Allergy Appl. Immunol. 94:137-140[Medline]. |
| 50. | Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385-409[Medline]. |
| 51. | Siebert, P. D., and J. W. Larrick. 1992. Competitive PCR. Nature 359:557-558[Medline]. |
| 52. | Siebert, P. D., and J. W. Larrick. 1993. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. BioTechniques. 14:244-249. [Medline] |
| 53. | Smith, C. J., R. F. Levine, and J. M. Mansfield. 1982. Cloning of African trypanosomes in mice immunosuppressed by cyclophosphamide treatment. Am. J. Trop. Med. Hyg. 31:1098-1102. |
| 54. | Snapper, C. M., and F. D. Finkelman. 1993. Immunoglobulin class switching, p. 837-864. In W. E. Paul (ed.), Fundamental Immunology, 3rd ed. Raven Press, New York, N.Y. |
| 55. | Snapper, C. M., F. D. Finkelman, and W. E. Paul. 1988. Regulation of IgG1 and IgE production by interleukin 4. Immunol. Rev. 102:51-75[Medline]. |
| 56. | Snapper, C. M., K. B. Marcu, and P. Zelazowski. 1997. The immunoglobulin class switch: beyond "accessibility". Immunity 6:217-223[Medline]. |
| 57. | Snapper, C. M., and J. J. Mond. 1996. A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J. Immunol. 157:2229-2233[Abstract]. |
| 58. | Snapper, C. M., and J. J. Mond. 1993. Towards a comprehensive view of immunoglobulin synthesis by CD4+ T cell clones. Immunol. Today 12:15. |
| 59. |
Snapper, C. M., and W. E. Paul.
1987.
Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.
Science
236:944-947 |
| 60. | Snapper, C. M., C. Peschel, and W. E. Paul. 1988. IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140:2121-2127[Abstract]. |
| 61. | Snapper, C. M., F. R. Rosas, L. Jin, C. Wortham, M. R. Kehry, and J. J. Mond. 1995. Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J. Immunol. 155:5582-5589[Abstract]. |
| 62. | Snapper, C. M., H. Yamaguchi, M. A. Moorman, and J. J. Mond. 1994. An in vitro model for T cell-independent induction of humoral immunity. A requirement for NK cells. J. Immunol. 152:4884-4892[Abstract]. |
| 63. | Snapper, C. M., H. Yamaguchi, M. A. Moorman, R. Sneed, D. Smoot, and J. J. Mond. 1993. Natural killer cells induce activated murine B cells to secrete Ig. J. Immunol. 151:5251-5260[Abstract]. |
| 64. | Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79-146[Medline]. |
| 65. |
Sternberg, J. M., and N. A. Mabbott.
1996.
Nitric oxide-mediated suppression of T cell responses during Trypanosoma brucei infection soluble trypanosome products and interferon-gamma are synergistic inducers of nitric oxide synthase.
Eur. J. Immunol.
26:539-543[Medline].
|
| 66. | Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255-258[Medline]. |
| 67. | Theodos, C. M., and J. M. Mansfield. 1990. Regulation of B cell responses to the variant surface glycoprotein molecule in trypanosomiasis. II. Down-regulation of idiotype expression is associated with the appearance of lymphocytes expressing antiidiotypic receptors. J. Immunol. 144:4022-4029[Abstract]. |
| 68. | Theodos, C. M., D. M. Reinitz, and J. M. Mansfield. 1990. Regulation of B cell responses to the variant surface glycoprotein (VSG) molecule in trypanosomiasis. I. Epitope specificity and idiotypic profile of monoclonal antibodies to the VSG of Trypanosoma brucei rhodesiense. J. Immunol. 144:4011-4021[Abstract]. |
| 69. |
Toellner, K.-M.,
A. Gulbranson-Judge,
D. R. Taylor,
D. M. Sze, and C. M. MacLennan.
1996.
Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation.
J. Exp. Med.
183:2303-2312 |
| 70. | Van Kooten, C., and J. Banchereau. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77[Medline]. |
| 71. | Vickerman, K., and A. G. Luckins. 1969. Localization of variable antigens in the surface coat of Trypanosoma brucei using ferritin conjugated antibody. Nature 224:1125-1126[Medline]. |
| 72. | Wellhausen, S. R., and J. M. Mansfield. 1980. Characteristics of the splenic suppressor cell-target cell interaction in experimental African trypanosomiasis. Cell. Immunol. 54:414-424[Medline]. |
| 73. |
Wellhausen, S. R., and J. M. Mansfield.
1979.
Lymphocyte function in experimental African trypanosomiasis. II. Splenic suppressor cell activity.
J. Immunol.
122:818-824 |
| 74. |
Wen, B. L.,
W. Pao,
F. S. Wong,
Q. Peng,
J. Craft,
B. Zheng,
G. Kelsoe,
L. Dianda,
M. J. Owen, and A. C. Hayday.
1996.
Germinal center formation, immunoglobulin class switching and autoantibody production driven by "non / " T cells.
J. Exp. Med.
183:2271-2282 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»